Tau Toxicity in the Synapses

Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease. Here is the latest research on Tau Toxicity in the Synapses.

July 1, 2020

Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats

Fundamental & Clinical Pharmacology
Adel A GomaaMariam A Nicola
July 2, 2020
Open Access

Insights into lncRNAs in Alzheimer's Disease Mechanisms

RNA Biology
Dingfeng LiQiang Liu
July 1, 2020
Review

Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction

Journal of Alzheimer's Disease : JAD
Ernesto SolisErin R Hascup
July 2, 2020

Excess tau PET ligand retention in elderly patients with major depressive disorder

Molecular Psychiatry
Sho MoriguchiMakoto Higuchi
July 1, 2020

Deciphering Alzheimer's disease: predicting new therapeutic strategies via improved understanding of biology and pathogenesis

Expert Opinion on Therapeutic Targets
Rita Khoury, George T Grossberg
June 27, 2020

An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Richard J CaselliGuojun Bu
June 18, 2020
Review
Open Access

Pathophysiological Mechanisms of Cognitive Impairment and Neurodegeneration by Toxoplasma gondii Infection

Brain Sciences
Gloria Ortiz-GuerreroMauricio O Nava-Mesa
June 25, 2020
Review
Open Access

Heart and Brain: Complex Relationships for Left Ventricular Dysfunction

Current Cardiology Reports
Gianlorenzo DanieleFederica Del Monte
June 26, 2020
Review
Open Access

The Role of P2X7 Receptor in Alzheimer's Disease

Frontiers in Molecular Neuroscience
Linda FrancistiováMiguel Díaz-Hernández
June 23, 2020
Review

Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers ?

Protein Science : a Publication of the Protein Society
Jacques FantiniNouara Yahi
June 26, 2020
Open Access

Oligomeric Forms of Human Amyloid-Beta(1-42) Inhibit Antigen Presentation

Frontiers in Immunology
Christoph GerickeMaria Teresa Ferretti
July 1, 2020
Open Access

Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid Angiopathy

Frontiers in Neurology
Bettina M FoidlChristian Humpel
June 24, 2020

Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Marta Milà-AlomàALFA study
June 20, 2020

Amyloid-β plaques may be reduced in advanced stages of cerebral amyloid angiopathy in the elderly

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Koichi OkamotoMasamitsu Takatama

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tau-toxicity-in-the-synapses/cdd881a9-f241-4cd7-9cd4-a56c0bdb1aba